Genome editing approach for generation of isogenic cell lines modelling Huntington's disease in vitro
- Authors: Malakhova A.A1,2,3, Sorokin M.A1,2,3, Sorokina A.E1,2,3, Malankhanova T.B1,2,3,4, Mazurok N.A1,2,3, Medvedev S.P1,2,3, Zakian S.M1,2,3
-
Affiliations:
- Federal Research Center Institute of Cytology and Genetics, the Siberian Branch of the Russian Academy of Sciences
- Institute of Chemical Biology and Fundamental Medicine, the Siberian Branch of the Russian Academy of Sciences
- State Research Institute of Circulation Pathology, Ministry of Healthcare of the Russian Federation
- National Research University Novosibirsk State University
- Issue: Vol 11, No 2 (2016)
- Pages: 106-113
- Section: Articles
- URL: https://genescells.ru/2313-1829/article/view/120601
- DOI: https://doi.org/10.23868/gc120601
- ID: 120601
Cite item
Abstract
Keywords
Full Text
About the authors
A. A Malakhova
Federal Research Center Institute of Cytology and Genetics, the Siberian Branch of the Russian Academy of Sciences; Institute of Chemical Biology and Fundamental Medicine, the Siberian Branch of the Russian Academy of Sciences; State Research Institute of Circulation Pathology, Ministry of Healthcare of the Russian Federation
Email: amal@bionet.nsc.ru
Novosibirsk, Russia
M. A Sorokin
Federal Research Center Institute of Cytology and Genetics, the Siberian Branch of the Russian Academy of Sciences; Institute of Chemical Biology and Fundamental Medicine, the Siberian Branch of the Russian Academy of Sciences; State Research Institute of Circulation Pathology, Ministry of Healthcare of the Russian FederationNovosibirsk, Russia
A. E Sorokina
Federal Research Center Institute of Cytology and Genetics, the Siberian Branch of the Russian Academy of Sciences; Institute of Chemical Biology and Fundamental Medicine, the Siberian Branch of the Russian Academy of Sciences; State Research Institute of Circulation Pathology, Ministry of Healthcare of the Russian FederationNovosibirsk, Russia
T. B Malankhanova
Federal Research Center Institute of Cytology and Genetics, the Siberian Branch of the Russian Academy of Sciences; Institute of Chemical Biology and Fundamental Medicine, the Siberian Branch of the Russian Academy of Sciences; State Research Institute of Circulation Pathology, Ministry of Healthcare of the Russian Federation; National Research University Novosibirsk State UniversityNovosibirsk, Russia
N. A Mazurok
Federal Research Center Institute of Cytology and Genetics, the Siberian Branch of the Russian Academy of Sciences; Institute of Chemical Biology and Fundamental Medicine, the Siberian Branch of the Russian Academy of Sciences; State Research Institute of Circulation Pathology, Ministry of Healthcare of the Russian FederationNovosibirsk, Russia
S. P Medvedev
Federal Research Center Institute of Cytology and Genetics, the Siberian Branch of the Russian Academy of Sciences; Institute of Chemical Biology and Fundamental Medicine, the Siberian Branch of the Russian Academy of Sciences; State Research Institute of Circulation Pathology, Ministry of Healthcare of the Russian FederationNovosibirsk, Russia
S. M Zakian
Federal Research Center Institute of Cytology and Genetics, the Siberian Branch of the Russian Academy of Sciences; Institute of Chemical Biology and Fundamental Medicine, the Siberian Branch of the Russian Academy of Sciences; State Research Institute of Circulation Pathology, Ministry of Healthcare of the Russian FederationNovosibirsk, Russia
References
- Cong L., Ran F.A., Cox D. et al. Multiplex genome engineering using CRISPR/Cas systems. Science 2013; 339(6121): 819-23.
- Rubinsztein D.C., Carmichael J. Huntington's disease: molecular basis of neurodegeneration. Expert. Rev. Mol. Med. 2004; 5t20): 1-21.
- Walker FO. Huntington's disease. Lancet 2007; 369(9557): 218-28.
- Juopperi T.A., Kim W.R., Chiang C.-H. et al. Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntington's disease patient cells. Mol. Brain. 2012; 5: 17.
- Немудрый А.А., Валетдинова К.Р., Медведев С.П. и др. Системы редактирования геномов TALEN и CRISPR/Cas инструменты открытий. Acta Naturae 2014; 6t3 (22)): 20-42.
- Ran F.A., Hsu P.D., Wright J. et al. Genome engineering using the CRISPR-Cas9 system. Nat. Protoc. 2013; 8(11): 2281-308.
- Hsu P.D., Scott D.A., Weinstein J.A. et al. DNA targeting specificity of RNA-guided Cas9 nucleases. Nat. Biotechnol. 2013; 31(9): 827-32.
- Camnasio S., Carri A.D., Lombardo A. et al. The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington's disease patients demonstrates mutation related enhanced lysosomal activity. Neurobiol. Dis. 2012; 46(1): 41-51.
- Wu L.L.-Y. Zhou X.F. Huntingtin associated protein 1 and its functions. Cell Adhes. Migr. 2009; 3(1): 71-6.